Back

Growth differentiation factor 15 is an independent marker of risk of major bleeding in atrial fibrillation: insights from the RE-LY trial

28 August 2016 (16:10 - 16:17)
Organised by:
Congress Presentation Part of: The relevance of biomarkers: a never ending story Biomarkers ESC Premium Access ESC Congress 2016

About the speaker

Photo
Associate Professor Ziad Hijazi

Uppsala University, Uppsala (Sweden)

6 More presentations in this session

Presentation thumbnail
Impact of smoking on circulating troponin I concentrations and cardiovascular events in the general population: The HUNT Study
Doctor M. Lyngbakken (Nordbyhagen, NO)
Abstract
Presentation thumbnail
Secretoneurin levels provide prognostic information after cardiac surgery
Doctor J. Brynildsen (Nordbyhagen, NO)
Abstract Slides
Presentation thumbnail
Renin, aldosterone, the aldosterone-to-renin ratio and incident hypertension among normotensive subjects from the population
Doctor N. Arnold (Hamburg, DE)
Abstract
Presentation thumbnail
Lipoprotein(a) concentrations do not associate with coronary atheroma progression or cardiovascular events during high-intensity statin therapy: insights from SATURN
Doctor S. Nicholls (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Prediction of contrast induced nephropathy using novel biomarkers following elective contrast coronary angiography
Doctor M. Connolly (Portadown, GB)
Abstract Slides

Access the full session

Session thumbnail
The relevance of biomarkers: a never ending story

The Event

Event poster

ESC Congress 2016

28 August 2016 16:10 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources